awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q27009769-0FDAA643-7206-451F-A052-A1891BEE0D8A
Q27009769-0FDAA643-7206-451F-A052-A1891BEE0D8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27009769-0FDAA643-7206-451F-A052-A1891BEE0D8A
An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations
P2860
Q27009769-0FDAA643-7206-451F-A052-A1891BEE0D8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27009769-0FDAA643-7206-451F-A052-A1891BEE0D8A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
19e61eb8abfe0a37fdf82c3e00a0a182cf590246
P2860
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group